Robert L. Redner
Experienced in Hairy Cell Leukemia (HCL)

Dr. Robert L. Redner

Hematology Oncology
UPMC
UPMC Hillman Cancer Center
5115 Centre Avenue, Hillman Cancer Center, 
Pittsburgh, PA 
On Staff At
Accepting New Patients
Offers Telehealth

Experienced in Hairy Cell Leukemia (HCL)
UPMC
UPMC Hillman Cancer Center
5115 Centre Avenue, Hillman Cancer Center, 
Pittsburgh, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Robert Redner is a Hematologist Oncology provider in Pittsburgh, Pennsylvania. Dr. Redner is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Redner is currently accepting new patients.

His clinical research consists of co-authoring 33 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Harvard Medical School
Residency
Johns Hopkins University School of Medicine
Specialties
Hematology Oncology
Licenses
Specialist in PA
Board Certifications
American Board Of Internal Medicine
American Board Of Internal Medicine
American Board Of Internal Medicine
Fellowships
David Geffen School of Medicine at UCLA
Hospital Affiliations
Magee Womens Hospital Of Upmc Health System
Upmc Presbyterian Shadyside
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

UPMC Hillman Cancer Center
5115 Centre Avenue, Hillman Cancer Center, Pittsburgh, PA 15232
Call: 412-946-2861

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


2 Clinical Trials

Randomized Trial of Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia (AML)
Randomized Trial of Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia (AML)
Enrollment Status: Active_not_recruiting
Publish Date: June 15, 2025
Intervention Type: Drug
Study Drugs: Gilteritinib, Midostaurin, Daunorubicin, Cytarabine
Study Phase: Phase 2
A Phase 3, Randomized, Open-Label, Crossover Study of ASTX727 (Cedazuridine and Decitabine Fixed-Dose Combination) Versus IV Decitabine in Subjects With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), and Acute Myeloid Leukemia (AML)
A Phase 3, Randomized, Open-Label, Crossover Study of ASTX727 (Cedazuridine and Decitabine Fixed-Dose Combination) Versus IV Decitabine in Subjects With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), and Acute Myeloid Leukemia (AML)
Enrollment Status: Completed
Publish Date: August 27, 2024
Intervention Type: Drug
Study Drugs: Cedazuridine, Decitabine
Study Phase: Phase 3
View 1 Less Clinical Trial

33 Total Publications

Ziftomenib in Relapsed or Refractory NPM1-Mutated AML.
Ziftomenib in Relapsed or Refractory NPM1-Mutated AML.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 25, 2025
View All 33 Publications
Similar Doctors
Advanced in Hairy Cell Leukemia (HCL)
Dr. Stewart L. Lancaster
Hematology Oncology | Oncology
Advanced in Hairy Cell Leukemia (HCL)
Dr. Stewart L. Lancaster
Hematology Oncology | Oncology
605 Sharon Rd, 
Beaver, PA 
 (26.0 miles away)
724-774-0778
Languages Spoken:
English
See accepted insurances

Stewart Lancaster is a Hematologist Oncology specialist and an Oncologist in Beaver, Pennsylvania. Dr. Lancaster is rated as an Advanced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Pleuropulmonary Blastoma, and Multiple Myeloma.

Dhaval R. Mehta
Advanced in Hairy Cell Leukemia (HCL)
Dr. Dhaval R. Mehta
Hematology Oncology
Advanced in Hairy Cell Leukemia (HCL)
Dr. Dhaval R. Mehta
Hematology Oncology

UPMC Hillman Cancer Center

400 Oxford Drive, Suite 102, 
Monroeville, PA 
 (9.2 miles away)
412-374-1441
Languages Spoken:
English, Gujarati , Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Dhaval R. Mehta, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Mehta treats all types of cancer and has special interest in hematological disorders and solid tumors, and clinical trials in the community setting. Dr. Mehta is rated as a Distinguished provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Polycythemia Vera, Paget Disease of the Breast, Thrombocytopenia, and Pleuropulmonary Blastoma.

Ibrahim Sbeitan
Advanced in Hairy Cell Leukemia (HCL)
Dr. Ibrahim Sbeitan
Hematology Oncology
Advanced in Hairy Cell Leukemia (HCL)
Dr. Ibrahim Sbeitan
Hematology Oncology

UPMC Hillman Cancer Center At John P. Murtha Pavilion

337 Somerset Street, 
Johnstown, PA 
 (53.9 miles away)
814-961-3733
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ibrahim Sbeitan, MD, specializes in hematology oncology and is board-certified in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine. He practices at UPMC Hillman Cancer Center. Dr. Sbeitan received his medical degree from the University of Jordan School of Medicine and completed his residency at Gundersen Medical Foundation in La Crosse, Wisconsin, followed by a fellowship at the University of Pittsburgh School of Medicine. Dr. Sbeitan is rated as a Distinguished provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Chronic Familial Neutropenia, Lynch Syndrome, Paget Disease of the Breast, and Urothelial Cancer.

VIEW MORE HAIRY CELL LEUKEMIA (HCL) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Redner's expertise for a condition
ConditionClose
    • Distinguished
    • Acute Myeloid Leukemia (AML)
      Dr. Redner is
      Distinguished
      . Learn about Acute Myeloid Leukemia (AML).
      See more Acute Myeloid Leukemia (AML) experts
    • Leukemia
      Dr. Redner is
      Distinguished
      . Learn about Leukemia.
      See more Leukemia experts
    • Advanced
    • Acute Myeloblastic Leukemia with Maturation
      Dr. Redner is
      Advanced
      . Learn about Acute Myeloblastic Leukemia with Maturation.
      See more Acute Myeloblastic Leukemia with Maturation experts
    • Acute Myeloblastic Leukemia without Maturation
      Dr. Redner is
      Advanced
      . Learn about Acute Myeloblastic Leukemia without Maturation.
      See more Acute Myeloblastic Leukemia without Maturation experts
    • Acute Promyelocytic Leukemia
      Dr. Redner is
      Advanced
      . Learn about Acute Promyelocytic Leukemia.
      See more Acute Promyelocytic Leukemia experts
    • Bone Marrow Aspiration
      Dr. Redner is
      Advanced
      . Learn about Bone Marrow Aspiration.
      See more Bone Marrow Aspiration experts
    • Childhood Acute Myeloid Leukemia
      Dr. Redner is
      Advanced
      . Learn about Childhood Acute Myeloid Leukemia.
      See more Childhood Acute Myeloid Leukemia experts
    • Thrombocytopenia
      Dr. Redner is
      Advanced
      . Learn about Thrombocytopenia.
      See more Thrombocytopenia experts
    • Experienced
    • Acute Lymphoblastic Leukemia (ALL)
      Dr. Redner is
      Experienced
      . Learn about Acute Lymphoblastic Leukemia (ALL).
      See more Acute Lymphoblastic Leukemia (ALL) experts
    • Acute Monoblastic Leukemia (AmoL)
      Dr. Redner is
      Experienced
      . Learn about Acute Monoblastic Leukemia (AmoL).
      See more Acute Monoblastic Leukemia (AmoL) experts
    • Acute Mountain Sickness
      Dr. Redner is
      Experienced
      . Learn about Acute Mountain Sickness.
      See more Acute Mountain Sickness experts
    • Agranulocytosis
      Dr. Redner is
      Experienced
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    • Anemia
      Dr. Redner is
      Experienced
      . Learn about Anemia.
      See more Anemia experts
    • Ataxia-Pancytopenia Syndrome
      Dr. Redner is
      Experienced
      . Learn about Ataxia-Pancytopenia Syndrome.
      See more Ataxia-Pancytopenia Syndrome experts
    View All 46 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.